Ocular Therapeutix Inc’s recently made public that its Director LINDSTROM RICHARD L MD acquired Company’s shares for reported $69600.0 on May 08 ’25. In the deal valued at $6.96 per share,10,000 shares were bought. As a result of this transaction, LINDSTROM RICHARD L MD now holds 172,704 shares worth roughly $1.21 million.
Then, Dugel Pravin sold 21,475 shares, generating $147,533 in total proceeds. Upon selling the shares at $6.87, the insider now owns 3,520,318 shares.
Before that, Heier Jeffrey S. sold 3,061 shares. Ocular Therapeutix Inc shares valued at $21,029 were divested by the Chief Scientific Officer at a price of $6.87 per share. As a result of the transaction, Heier Jeffrey S. now holds 265,998 shares, worth roughly $1.86 million.
William Blair initiated its Ocular Therapeutix Inc [OCUL] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in mid March with a ‘”an Outperform”‘ rating. Needham began covering OCUL with “Buy” recommendation on March 11, 2025. Scotiabank started covering the stock on October 16, 2024. It rated OCUL as “a Sector outperform”.
Price Performance Review of OCUL
On Tuesday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock fall -5.28% to $7.00. Over the last five days, the stock has lost -2.44%. Ocular Therapeutix Inc shares have fallen nearly -18.03% since the year began. Nevertheless, the stocks have risen 19.86% over the past one year. While a 52-week high of $11.77 was reached on 01/07/25, a 52-week low of $4.79 was recorded on 03/04/25. SMA at 50 days reached $7.47, while 200 days put it at $8.50.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 6.79, which if violated will result in even more drops to 6.57. On the upside, there is a resistance level at 7.39. A further resistance level may holdings at 7.77. The Relative Strength Index (RSI) on the 14-day chart is 44.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.21%. Stochastics %K at 15.09% indicates the stock is a buying.
